Simcere Pharmaceutical Group Limited

Simcere Pharmaceutical Group Limitedverified

2096.HK

Price:

$8.24

Market Cap:

$18.93B

Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and sale of pharmaceutical products for distributors and pharmacy chains and other pharmaceutical manufacturers in China. It focusses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. The company's principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; Softan, a rosuvastatin calcium tablet; ZAILIN, an amoxicillin granules/dispersible tablet/capsule; Iremod, an iguratimod tablet; Antine, a diclof...[Read more]

Industry

Biotechnology

IPO Date

2020-10-27

Stock Exchange

HKSE

Ticker

2096.HK

The PE Ratio as of May 2025 (TTM) for Simcere Pharmaceutical Group Limited (2096.HK) is 26.58

According to Simcere Pharmaceutical Group Limited’s latest financial reports and current stock price. The company's current PE Ratio is 26.58. This represents a change of 21.54% compared to the average of 21.87 of the last 4 quarters.

Simcere Pharmaceutical Group Limited (2096.HK) Historical PE Ratio (quarterly & annually)

How has 2096.HK PE Ratio performed in the past?

The mean historical PE Ratio of Simcere Pharmaceutical Group Limited over the last ten years is 28.90. The current 26.58 PE Ratio has changed 9.10% with respect to the historical average. Over the past ten years (40 quarters), 2096.HK's PE Ratio was at its highest in in the March 2022 quarter at 214.06. The PE Ratio was at its lowest in in the December 2012 quarter at -11.16.

Quarterly (TTM)
Annual

Average

28.90

Median

25.47

Minimum

12.67

Maximum

67.96

Simcere Pharmaceutical Group Limited (2096.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Simcere Pharmaceutical Group Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 308.19%

Maximum Annual PE Ratio = 67.96

Minimum Annual Increase = -56.80%

Minimum Annual PE Ratio = 12.67

Quarterly (TTM)
Annual
YearPE RatioChange
202422.994.45%
202322.01-23.51%
202228.78127.11%
202112.67-56.80%
202029.3415.20%
201925.47-25.59%
201834.22-49.64%
201767.96308.19%

Simcere Pharmaceutical Group Limited (2096.HK) Average PE Ratio

How has 2096.HK PE Ratio performed in the past?

The current PE Ratio of Simcere Pharmaceutical Group Limited (2096.HK) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

24.60

5-year avg

23.16

10-year avg

28.90

Simcere Pharmaceutical Group Limited (2096.HK) PE Ratio vs. Peers

How is 2096.HK’s PE Ratio compared to its peers?

Simcere Pharmaceutical Group Limited’s PE Ratio is greater than JW (Cayman) Therapeutics Co. Ltd (-1.04), greater than CARsgen Therapeutics Holdings Limited (0), greater than RemeGen Co., Ltd. (-17.76), greater than Shanghai Junshi Biosciences Co., Ltd. (-22.91), greater than Everest Medicines Limited (-13.62),

Build a custom stock screener for Simcere Pharmaceutical Group Limited (2096.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Simcere Pharmaceutical Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Simcere Pharmaceutical Group Limited (2096.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Simcere Pharmaceutical Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Simcere Pharmaceutical Group Limited's PE Ratio?

How is the PE Ratio calculated for Simcere Pharmaceutical Group Limited (2096.HK)?

What is the highest PE Ratio for Simcere Pharmaceutical Group Limited (2096.HK)?

What is the 3-year average PE Ratio for Simcere Pharmaceutical Group Limited (2096.HK)?

What is the 5-year average PE Ratio for Simcere Pharmaceutical Group Limited (2096.HK)?

How does the current PE Ratio for Simcere Pharmaceutical Group Limited (2096.HK) compare to its historical average?